Inventor

Gal Markel

Inventor

Haifa, IL

Overview

23→

Patents

2009–2021

Patent span

Human necessities

Primary field (CPC A)

Patents· 23 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes16%

C07KPeptides14%

G01NInvestigating or analysing materials by determining their chemical or physical properties11%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations10%

C12NMicroorganisms or enzymes7%

A61BDiagnosis5%

A23BPreservation of foods, foodstuffs or non-alcoholic beverages4%

A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for4%

A41BShirts4%

A41CCorsets4%

PatentTitleYear

10,993,490Wearable items providing physiological, environmental and situational parameter monitoring2021 10,765,719CEACAM based antibacterial agents2020 10,663,464CEACAM1 based point-of-care cancer diagnostic2020 10,550,196Humanized antibodies against CEACAM12020 10,188,760Modulation of immunity and CEACAM1 activity2019 10,105,097Wearable items providing physiological, environmental and situational parameter monitoring2018 9,889,175'CEACAM based antibacterial agents'2018 9,795,696'CEACAM1 based cancer therapy and diagnosis'2017 9,771,431'Antibodies to carcinoembryonic antigen-related cell adhesion molecule (CEACAM)'2017 9,731,036'CEACAM1 mediated protective immunity'2017 9,694,046'CEACAM based antibacterial agents'2017 9,526,452'Wearable items providing physiological, environmental and situational parameter monitoring'2016 9,451,895'Mobile communication device and other devices with cardiovascular monitoring capability'2016 9,261,507'Anti CEACAM1 antibodies and methods of using same'2016 9,238,838'Microrna patterns for the diagnosis, prognosis and treatment of melanoma'2016 9,131,892'Wearable items providing physiological, environmental and situational parameter monitoring'2015 8,980,549'MicroRNA patterns for the diagnosis, prognosis and treatment of melanoma'2015 8,815,248'Modulation of immunity and CEACAM1 activity'2014 8,735,157'CEACAM1 mediated protective immunity'2014 8,598,322'Anti CEACAM1 antibodies and methods of using same'2013 8,298,544'CEACAM based antibacterial agents'2012 8,267,095'Colored smoke module for cigarette'2012 7,546,839'Colored smoke module for cigarette'2009

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2009–2021Patents assigned to MARKEL GAL (19)· patent assignee history

2009–2021Based in Haifa, IL· patent location history

2013–2017Patents assigned to TEL HASHOMER MEDICAL RES INFRASTRUCTURE & SERVICES LTD (5)· patent assignee history

2013–2016Patents assigned to UNIV RAMOT (4)· patent assignee history

2013–2017Based in Tel Aviv, IL· patent location history

2015Patents assigned to EDRY LIAT (1)· patent assignee history

2017–2020Patents assigned to CCAM BIOTHERAPEUTICS LTD (2)· patent assignee history

2020Based in Ramat Gan, IL· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
MARKEL GALself	19	2009–2021
TEL HASHOMER MEDICAL RES INFRASTRUCTURE & SERVICES LTD	5	2013–2017
UNIV RAMOT	4	2013–2016
CCAM BIOTHERAPEUTICS LTD	2	2017–2020
EDRY LIAT	1	2015

Locations

Location	Patents	Span
Haifa, IL	17	2009–2021
Tel Aviv, IL	5	2013–2017
Ramat Gan, IL	1	2020